Trinity Biotech plc(TRIB)Earnings, Financials & Key RatiosTrinity Biotech plc (TRIB) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q4
which suggests an unsustainable path toward potential insolvency.
Trinity Biotech plc (TRIB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Trinity Biotech plc (TRIB) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 16, 2026 | $0.23vs $0.31+25.8% | —vs $11M |
| Q2 2026 | Apr 30, 2026 | $0.90vs $0.32-181.3% | $11Mvs $15M-26.2% |
| Q4 2025 | Dec 23, 2025 | $0.32vs $0.51+37.3% | $14Mvs $11M+35.7% |
| Q2 2025 | May 15, 2025 | $1.02vs $0.30-240.0% | $16Mvs $16M-0.9% |
Recent stock market news and headlines for Trinity Biotech plc (TRIB)
- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environments
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets
Key metrics vs top competitors for Trinity Biotech plc (TRIB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.36 | $3.75M | -0.18 | -28.87% | -85.36% | — | — | |
| $4.46 | $320.97M | -4.74 | -38.1% | -61.93% | -15.09% | — | |
| $1.86 | $10.88M | -0.43 | — | — | — | — | |
| $95.66 | $2.18B | 37.96 | 13.53% | 24.35% | 16.19% | — | |
| $13.79 | $938.85M | -0.83 | -1.89% | -45.57% | -56.31% | — | |
| $4.48 | $578.56M | -8.62 | 0.52% | -36.25% | -20.77% | — |
Trinity Biotech plc (TRIB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when TRIB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Trinity Biotech plc (TRIB) stock FAQ — growth, dividends, profitability & financials explained
Trinity Biotech plc (TRIB) reported $43.9M in revenue for fiscal year 2025. This represents a 509% increase from $7.2M in 1996.
Trinity Biotech plc (TRIB) saw revenue decline by 28.9% over the past year.
Trinity Biotech plc (TRIB) reported a net loss of $37.4M for fiscal year 2025.
Trinity Biotech plc (TRIB) had negative free cash flow of $6.3M in fiscal year 2025, likely due to heavy capital investments.
